BROWSE·page 517 of 595

Browse EX-10 agreements

7,140 total material contract exhibits.


EX-10.16

StepStone Group Inc.

STEPSTONE GROUP INC.

2023 EMPLOYEE STOCK PURCHASE PLAN

Adopted by the Board: July 13, 2023

Approved by the Stockholders: September 13, 2023

Effective Date: September 13, 2023

Amended: February 23, 2026

1.PURPOSE.

The purpose of this StepStone Group Inc. 2023 Employee Stock Purchase Plan (the “Plan”) is to provide employees of the Company and its Designated Affiliates with an opportunity to purchase Common Stock through accumulated Contributions.

2.DEFINITIONS.

(a)“Administrator” means the Compensation Committee of the Board (or any successor committee) or such other committee as designated by the Board to administer the Plan under Section 14.

(b)“Affiliate” means, at the time of determination, any “parent” or “subsidiary” of the Company, as such terms are defined in Rule 405 of the Securities Act. The Administrator will have the authority to determine the time or times at which “parent” or “subsidiary” status is determined within the foregoing definition.

EX-10.16·10-K·CIK 1796022·ACC 0001628280-26-038446·Filed May 27, 2026, 16:02 ET

EX-10.2

Q32 Bio Inc.

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 26, 2026, is entered into by and among Q32 BIO INC.,a Delaware corporation (the “Company”), and the several investors signatory hereto (individually as an “Investor” and collectively together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

WHEREAS:

EX-10.2·8-K·CIK 1661998·ACC 0001193125-26-241846·Filed May 27, 2026, 16:01 ET

EX-10.1

Q32 Bio Inc.

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of May 26, 2026 by and among Q32 Bio Inc., a Delaware corporation (the “Company”), and each of the entities listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act;

WHEREAS, the Company desires to sell to the Investors, and each Investor desires to purchase from the Company, severally and not jointly, upon the terms and subject to the conditions stated in this Agreement, (A) shares (the “Initial Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and (B) pre-funded warrants to purchase shares of Common Stock substantially in the form attached hereto as Exhibit B (the “Pre-Funded Warrants” and together with the Initial Shares, the “Securities”); and

EX-10.1·8-K·CIK 1661998·ACC 0001193125-26-241846·Filed May 27, 2026, 16:01 ET

EX-10.1

Arbutus Biopharma Corp

ARBUTUS BIOPHARMA CORPORATION 2026 OMNIBUS SHARE AND INCENTIVE PLAN 1. PURPOSE The Plan is intended to (a) provide eligible persons with an incentive to contribute to the success of the Company and to operate and manage the Company’s business in a manner that will provide for the Company’s long-term growth and profitability to benefit its shareholders and other important stakeholders, including its employees and customers, and (b) provide a means of obtaining, rewarding and retaining key personnel. To this end, the Plan provides for the grant of awards of stock options, share appreciation rights, restricted shares, restricted share units, unrestricted shares, dividend equivalent rights, performance-based awards, and other equity-based awards. Any of these awards may, but need not, be made as performance incentives to reward the holders of such awards for the achievement of performance goals in accordance with the terms of the Plan. Stock options granted under the Plan may be nonqualified stock options or incentive stock options, as provided in the Plan. 2. DEFINITIONS For purposes of

EX-10.1·8-K·CIK 1447028·ACC 0001447028-26-000024·Filed May 27, 2026, 16:01 ET

SOFTWARE DEVELOPMENT AGREEMENT

This Software Development Agreement (“Agreement”) is made and entered into as of April 27, 2026 (“Effective Date”), by and between:

Developer: Centuno Company Limited, No.399, Interchange 21 Building, 33rd Floor, Sukhumvit Road, Khlong Toei Nuea Sub-district, Vadhana District, Bangkok Metropolis. Client: Luvulis Corporation, 6608 N Western Avenue 1121, Oklahoma City, OK 73116, USA.

RECITALS

WHEREAS, Developer provides software and API development services; and

WHEREAS, Client desires to engage Developer for the development of certain API infrastructure and related software components under the terms and conditions set forth herein.

NOW, THEREFORE, in consideration of the mutual covenants and promises herein contained, the parties agree as follows:

1. Development Services

EX-10.3·S-1/A·CIK 2123169·ACC 0002123169-26-000004·Filed May 27, 2026, 14:28 ET

EX-10.20

First Breach, Inc.

Exhibit 10.20

EX-10.20·S-1/A·CIK 1892704·ACC 0001493152-26-025360·Filed May 27, 2026, 13:48 ET

EX-10.19

First Breach, Inc.

Exhibit 10.19

EX-10.19·S-1/A·CIK 1892704·ACC 0001493152-26-025360·Filed May 27, 2026, 13:48 ET

EX-10.5

First Breach, Inc.

Exhibit 10.5

 

 

 

 

EX-10.5·S-1/A·CIK 1892704·ACC 0001493152-26-025360·Filed May 27, 2026, 13:48 ET

EX-10.4

First Breach, Inc.

LEASE AGREEMENT

THIS LEASE AGREEMENT (this “Lease”) is made as of February 1, 2022 (the “Effective Date”) by and between NEW HEIGHTS INDUSTRIAL PARK LLC, a Delaware limited liability company (“Landlord”), and FIRST BREACH INC., a Delaware corporation (“Tenant”).

R E C I T A L S

A.       Landlord is the owner of the improved real property located at 18450 Showalter Road, Hagerstown, Maryland 21742, which is more particularly described on Exhibit A (the “Property”).

B.       Tenant desires to lease a portion of the Property referred to as Bay 1 and Bay 2, comprising approximately 71,500 rentable square feet, as more particularly shown on Exhibit B (the “Premises”).

C.       Landlord has agreed to lease to Tenant, and Tenant has agreed to rent from Landlord, the Premises on the terms of this Lease.

NOW, THEREFORE, in consideration of the premises and the mutual covenants and conditions contained herein, Landlord and Tenant hereby agree as follows:

1.             Term.

EX-10.4·S-1/A·CIK 1892704·ACC 0001493152-26-025360·Filed May 27, 2026, 13:48 ET

EX-10.3

First Breach, Inc.

Exhibit 10.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EX-10.3·S-1/A·CIK 1892704·ACC 0001493152-26-025360·Filed May 27, 2026, 13:48 ET

EX-10.69

MONRO, INC.

Exhibit 10.69
200 Holleder Parkway, Rochester, NY 14615

April 13, 2021



Cindy L. Donovan

12 Port Meadow Trail

Fairport, NY 14550



Dear Cindy:

This letter will document certain terms with respect to your employment as Senior Vice President - Information Technology (“SVP-IT”) that Monro, Inc. (the “Company”) would like to provide to you:

1. Termination without Cause or with Good Reason – If your employment is terminated (a) by the Company without Cause (as defined herein), or (b) by you with Good Reason (as defined herein), the Company shall pay (in the normal course) to you the following amounts or benefits:
a. to the extent not yet paid, your base salary through the date of termination at the rate in effect on the date of termination;

EX-10.69·10-K·CIK 876427·ACC 0000876427-26-000007·Filed May 27, 2026, 08:29 ET

EX-10.1

MIRA PHARMACEUTICALS, INC.

EX-10.1·8-K·CIK 1904286·ACC 0001493152-26-025335·Filed May 27, 2026, 08:00 ET